Compared to PMB, which is a known LPS neutralizer, mutant peptide MC1-1 showed an enhanced ability to inhibit TNF-α and IL-6 production and to protect mice with endotoxemia from death at the same concentration. This evidence concerns the gene IL6 and serum lipopolysaccharide activity.